Literature DB >> 2798239

The RGO Generation II: muscle stimulation powered orthosis as a practical walking system for thoracic paraplegics.

M Solomonow1, R Baratta, S Hirokawa, N Rightor, W Walker, P Beaudette, H Shoji, R D'Ambrosia.   

Abstract

The RGO Generation II reciprocating gait orthosis was jointly developed by Louisiana State University Medical Center and Durr-Fillauer Medical, Inc, to overcome four problems encountered with the existing model: 1) The high energy cost of locomotion; 2) the great arm strength required for patients to stand up from the seated position without assistance; 3) difficulty (especially for patients with hamstring contracture) in remaining standing owing to failure of the knee latch to lock except in full extension; and 4) problems in balancing when ambulating on an incline. The RGO Generation II employs concurrent electrostimulation of the rectus femoris and hamstrings to assist in rising and balancing and a ratchet-type latching device to improve safety and stability in standing. Alternating stimulation of the rectus femoris and contralateral hamstrings are used for locomotion. Testing in six patients with thoracic paraplegia demonstrated an average 30+% reduction in energy expenditure at a walking speed of .05 m/s and a 15+% reduction at .37 m/s; improved mobility and better balance on inclines; and unassisted rising in all patients. Walking range was increased from an average of 100 m to an average of 800 m. More research is needed to provide stair-climbing ability and to further reduce energy expenditure.

Entities:  

Mesh:

Year:  1989        PMID: 2798239     DOI: 10.3928/0147-7447-19891001-06

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  13 in total

1.  Current status of walking orthoses for thoracic paraplegics.

Authors:  R D'Ambrosia; M Solomonow; R V Baratta
Journal:  Iowa Orthop J       Date:  1995

2.  Cycle-to-cycle control of swing phase of paraplegic gait induced by surface electrical stimulation.

Authors:  H M Franken; P H Veltink; G Baardman; R A Redmeyer; H B Boom
Journal:  Med Biol Eng Comput       Date:  1995-05       Impact factor: 2.602

Review 3.  Functional walking ability of paraplegic patients: comparison of functional electrical stimulation versus mechanical orthoses.

Authors:  Mohammad Taghi Karimi
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-07-22

4.  Training Persons with Spinal Cord Injury to Ambulate Using a Powered Exoskeleton.

Authors:  Pierre K Asselin; Manuel Avedissian; Steven Knezevic; Stephen Kornfeld; Ann M Spungen
Journal:  J Vis Exp       Date:  2016-06-16       Impact factor: 1.355

Review 5.  Rehabilitation robotics.

Authors:  H I Krebs; B T Volpe
Journal:  Handb Clin Neurol       Date:  2013

6.  Energy consumption of paraplegic locomotion using reciprocating gait orthosis.

Authors:  J Beillot; F Carré; G Le Claire; P Thoumie; B Perruoin-Verbe; A Cormerais; A Courtillon; E Tanguy; G Nadeau; P Rochcongar; J Dassonville
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

7.  On/off control in FES-induced standing up: a model study and experiments.

Authors:  A J Mulder; P H Veltink; H B Boom
Journal:  Med Biol Eng Comput       Date:  1992-03       Impact factor: 2.602

8.  Enhancing stance phase propulsion during level walking by combining FES with a powered exoskeleton for persons with paraplegia.

Authors:  Kevin H Ha; Hugo A Quintero; Ryan J Farris; Michael Goldfarb
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2012

9.  Standing-up exerciser based on functional electrical stimulation and body weight relief.

Authors:  M Ferrarin; E E Pavan; R Spadone; R Cardini; C Frigo
Journal:  Med Biol Eng Comput       Date:  2002-05       Impact factor: 2.602

10.  Device-Training for Individuals with Thoracic and Lumbar Spinal Cord Injury Using a Powered Exoskeleton for Technically Assisted Mobility: Achievements and User Satisfaction.

Authors:  Thomas Platz; Annett Gillner; Nicole Borgwaldt; Sylvia Kroll; Sybille Roschka
Journal:  Biomed Res Int       Date:  2016-08-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.